Xeris Biopharma Holdings
XERS
XERS
93 hedge funds and large institutions have $115M invested in Xeris Biopharma Holdings in 2021 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 20 increasing their positions, 35 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
93
Holders Change
-10
Holders Change %
-9.71%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
25
Increased
20
Reduced
35
Closed
35
Calls
$8.9M
Puts
$2.39M
Net Calls
+$6.5M
Net Calls Change
-$2.46M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$1.85M |
| 2 |
2
SG Americas Securities
New York
|
$994K |
| 3 |
SC
3
Sessa Capital
New York
|
$14.9M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$12.1M |
| 5 |
5
Renaissance Technologies
New York
|
$5.03M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$6.86M |
| 2 |
2
D.E. Shaw & Co
New York
|
$1.06M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$874K |
| 4 |
TA
4
Tamarack Advisers
Carlsbad,
California
|
$0 |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$517K |
